In addition, ACE2 gene expression was found to be higher in both subcutaneous and visceral AT when compared to lung cells in obese patients [15,16], as well as in the soluble form of ACE2 in patients with a metabolic syndrome [17]. This evidence concerns the gene ACE2 and metabolic syndrome.